Clinical Trial: A Phase 1, Randomized, Controlled, Latin-square, Open-label Study, to Evaluate the Effect of ADV7103 on Gastric pH Under Fed and Fasting Conditions in Adult Healthy Participants.

U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT07446881) titled 'A Phase 1, Randomized, Controlled, Latin-square, Open-label Study, to Evaluate the Effect of ADV7103 on Gastric pH Under Fed and Fasting Conditions in Adult Healthy Participants.' on Feb. 26.

Brief Summary: This was a Phase 1, single-center, randomized, controlled, Latin-square, open-label study to evaluate the effect of ADV7103 on the gastric pH, after administering a single oral dose of ADV7103 in healthy adult participants under fasting and fed conditions

Study Start Date: Feb. 25, 2025

Study Type: INTERVENTIONAL

Condition: EFFECT OF ADV7103 ON GASTRIC PH

Intervention: DRUG: ADV7103

EFFECT ON GASTRIC PH

Recruitment Status...